Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer

The variant, classified as 'B.1.617', has now been found in eight nations, with 70% of samples comprising mutations believed to have stemmed from India. Experts have termed the \"new double mutant strain\" a desi (Indian) variant

Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.

A total of 82,339 patients were discharged in the past 24 hours. As of April 14, India's total case tally stands at 1.38 crore; total recoveries 1.2 crore; active cases 13.6 lakh; and 1.72 lakh patients have died

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses

Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

In a tweet, RSS said Bhagwat has normal symptoms and has been admitted to Kingsway hospital in Nagpur.

Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac

The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would \"very shortly apply for permission to conduct clinical bridging trials in India,\" according to the report

The US Food and Drug Administration (FDA) cleared Moderna to speed up vaccine output by letting it fill a single vial with up to 15 doses

The National Advisory Committee on Immunization had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday

After a slow start, India is picking up the pace of its immunisation campaign as it tries to head off a new surge in infections that has brought the highest tallies of daily cases and deaths in months

The document, shared with EU officials and dated March 10, shows that the company now expects to deliver 30.1 million doses by the end of March, and another 20 million in April

Denmark said six other European countries had halted the use of a vaccine batch from AstraZeneca; The vaccine would be suspended for 14 days

Since the campaign began three weeks ago, just under 46,500 doses had been administered to frontline medical workers as of Friday

National Health Service (NHS) Secretary Amir Ashraf Khawaja while briefing the Public Accounts Committee on Thursday said that the Pakistan government has no plan to buy vaccines anytime soon

So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy

The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones